Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination

Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination.

Detalles Bibliográficos
Autores principales: Eshet, Yael, Tau, Noam, Alhoubani, Yousef, Kanana, Nayroz, Domachevsky, Liran, Eifer, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radiological Society of North America 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082565/
https://www.ncbi.nlm.nih.gov/pubmed/33904778
http://dx.doi.org/10.1148/radiol.2021210886
_version_ 1783685866609180672
author Eshet, Yael
Tau, Noam
Alhoubani, Yousef
Kanana, Nayroz
Domachevsky, Liran
Eifer, Michal
author_facet Eshet, Yael
Tau, Noam
Alhoubani, Yousef
Kanana, Nayroz
Domachevsky, Liran
Eifer, Michal
author_sort Eshet, Yael
collection PubMed
description Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination.
format Online
Article
Text
id pubmed-8082565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Radiological Society of North America
record_format MEDLINE/PubMed
spelling pubmed-80825652021-04-29 Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination Eshet, Yael Tau, Noam Alhoubani, Yousef Kanana, Nayroz Domachevsky, Liran Eifer, Michal Radiology Original Research Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination. Radiological Society of North America 2021-04-27 /pmc/articles/PMC8082565/ /pubmed/33904778 http://dx.doi.org/10.1148/radiol.2021210886 Text en 2021 by the Radiological Society of North America, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Original Research
Eshet, Yael
Tau, Noam
Alhoubani, Yousef
Kanana, Nayroz
Domachevsky, Liran
Eifer, Michal
Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
title Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
title_full Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
title_fullStr Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
title_full_unstemmed Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
title_short Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
title_sort prevalence of increased fdg pet/ct axillary lymph node uptake beyond 6 weeks after mrna covid-19 vaccination
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082565/
https://www.ncbi.nlm.nih.gov/pubmed/33904778
http://dx.doi.org/10.1148/radiol.2021210886
work_keys_str_mv AT eshetyael prevalenceofincreasedfdgpetctaxillarylymphnodeuptakebeyond6weeksaftermrnacovid19vaccination
AT taunoam prevalenceofincreasedfdgpetctaxillarylymphnodeuptakebeyond6weeksaftermrnacovid19vaccination
AT alhoubaniyousef prevalenceofincreasedfdgpetctaxillarylymphnodeuptakebeyond6weeksaftermrnacovid19vaccination
AT kanananayroz prevalenceofincreasedfdgpetctaxillarylymphnodeuptakebeyond6weeksaftermrnacovid19vaccination
AT domachevskyliran prevalenceofincreasedfdgpetctaxillarylymphnodeuptakebeyond6weeksaftermrnacovid19vaccination
AT eifermichal prevalenceofincreasedfdgpetctaxillarylymphnodeuptakebeyond6weeksaftermrnacovid19vaccination

Ejemplares similares